Evidence map›Paper›PMID 31303906›Full record

ArticleThe Pan African medical journal2019

Rectal stromal tumor with an exceptional liver and bone metastatic locations.

Dougaz Mohamed Wejih, Gouta Esma Leila, Chaouch Mohamed Ali, Nouira Ramzi, Bouasker Ibtissem, Dziri Chadli

Open access · goldAbstract readCase Reports
In one paragraph

Article in The Pan African medical journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Dougaz Mohamed WejihSurgery B Department, Charles Nicolle Hospital, Tunis, Tunisia.
Gouta Esma LeilaSurgery B Department, Charles Nicolle Hospital, Tunis, Tunisia.
Chaouch Mohamed AliSurgery B Department, Charles Nicolle Hospital, Tunis, Tunisia.
Nouira RamziSurgery B Department, Charles Nicolle Hospital, Tunis, Tunisia.
Bouasker IbtissemSurgery B Department, Charles Nicolle Hospital, Tunis, Tunisia.
Dziri ChadliSurgery B Department, Charles Nicolle Hospital, Tunis, Tunisia.
Hôpital Charles-Nicolle · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastrointestinal stromal tumours (GIST) are rare mesenchymal tumours which represent 1% to 3% of gastrointestinal neoplasm. Rectal location of GIST is extremely rare reaching 5% of GIST and only 0.1% of rectal tumours. They usually metastases to the liver (65%) and exceptionally to the bone (3%). We reported a case of rectal stromal tumour with an exceptional metastasis located in the rib. A 40-year-old man who presented with pelvic pain, associated with rectal syndrome, rectal bleeding and subocclusive episodes. Physical examination objectified a tough, budding rectal mass, with a smooth wall, localized 3cm above of anal margin. A Thoraco-abdominal computed tomography showed a large heterogeneous tissue mass, taking the whole pelvis, coming from the right-side wall of the rectum of 17.3 x 14cm. It was associated with liver and bone secondary locations. Biopsies confirmed the secondary locations of an intermediate risk GIST. Immunohistochemical study showed an overexpression of c-kit protein (CD117) and Dog1. Imatinib was prescribed to reduce the tumour size. Stromal metastatic rectal tumours in bone level are extremely rare conditions. The diagnosis is confirmed by histological examination with immune histochemical analysis. The prognosis remains poor in metastatic forms but it has been improved since the introduction of Imatinib.

Indexed as

AdultAntineoplastic AgentsBone NeoplasmsGastrointestinal Stromal TumorsHumansImatinib MesylateLiver NeoplasmsMaleRectal NeoplasmsTomography, X-Ray ComputedAntineoplastic AgentsImatinib Mesylategastrointestinal neoplasmmetastasesStromal tumor

Identifiers

PMID31303906
PMCPMC6607269
OpenAlexW2922584221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.